COVID-19 vaccination | Use only Covaxin for 15-18 age cohort: Bharat Biotech

COVID vaccine maker Bharat Biotech has appealed to healthcare workers to be “highly vigilant and ensure…

Bharat Biotech likely to get a pre-qualification approval from WHO by August | India News – Times of India

NEW DELHI: Bharat Biotech is likely to get a pre-qualification approval from WHO by August. The…

Covaxin reached 30 cities in 30 days: Bharat Biotech | India News – Times of India

HYDERABAD: Indigenously developed Covid-19 vaccine Covaxin has reached 30 cities in 30 days regardless of fairly…

Bharat Biotech needs to give more information for emergency use listing, says WHO | India News – Times of India

NEW DELHI: The World well being group (WHO) stated “more information” is “required” from Bharat Biotech,…

WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin | India News – Times of India

Consultant picture NEW YORK / GENEVA: The World well being group (WHO) mentioned “extra info” is…

Bharat Biotech submitted 90% of documentation to WHO for emergency use listing for Covaxin: Sources | India News – Times of India

NEW DELHI: Bharat Biotech Worldwide Restricted (BBIL) has conveyed to the federal government that it has…

Pediatric trials of Covaxin may begin in June: Bharat Biotech official | India News – Times of India

HYDERABAD: Bharath Biotech may begin medical trials of its COVID-19 vaccine Covaxin on kids from June,…